These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 35421449)
1. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity. van Leeuwen LPM; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk F; van Gorp ECM; de Wilt F; Bogers S; Gommers L; Geers D; Bruns AHW; Leavis HL; van Haga JW; Lemkes BA; van der Veen A; de Kruijf-Bazen SFJ; van Paassen P; de Leeuw K; van de Ven AAJM; Verbeek-Menken PH; van Wengen A; Arend SM; Ruten-Budde AJ; van der Ent MW; van Hagen PM; Sanders RW; Grobben M; van der Straten K; Burger JA; Poniman M; Nierkens S; van Gils MJ; de Vries RD; Dalm VASH J Allergy Clin Immunol; 2022 Jun; 149(6):1949-1957. PubMed ID: 35421449 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program. van Leeuwen LPM; Grobben M; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk FL; van Gils MJ; de Vries RD; Dalm VASH; Front Immunol; 2024; 15():1390022. PubMed ID: 38698851 [TBL] [Abstract][Full Text] [Related]
3. Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity. van Leeuwen LPM; Grobben M; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk FL; van Gils MJ; de Vries RD; Dalm VASH; J Clin Immunol; 2023 Aug; 43(6):1104-1117. PubMed ID: 37231290 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency. Arroyo-Sánchez D; Cabrera-Marante O; Laguna-Goya R; Almendro-Vázquez P; Carretero O; Gil-Etayo FJ; Suàrez-Fernández P; Pérez-Romero P; Rodríguez de Frías E; Serrano A; Allende LM; Pleguezuelo D; Paz-Artal E J Clin Immunol; 2022 Feb; 42(2):240-252. PubMed ID: 34787773 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. Hagin D; Freund T; Navon M; Halperin T; Adir D; Marom R; Levi I; Benor S; Alcalay Y; Freund NT J Allergy Clin Immunol; 2021 Sep; 148(3):739-749. PubMed ID: 34087242 [TBL] [Abstract][Full Text] [Related]
6. Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies. Amodio D; Ruggiero A; Sgrulletti M; Pighi C; Cotugno N; Medri C; Morrocchi E; Colagrossi L; Russo C; Zaffina S; Di Matteo G; Cifaldi C; Di Cesare S; Rivalta B; Pacillo L; Santilli V; Giancotta C; Manno EC; Ciofi Degli Atti M; Raponi M; Rossi P; Finocchi A; Cancrini C; Perno CF; Moschese V; Palma P Front Immunol; 2021; 12():727850. PubMed ID: 34671350 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects. Pham MN; Murugesan K; Banaei N; Pinsky BA; Tang M; Hoyte E; Lewis DB; Gernez Y J Allergy Clin Immunol; 2022 Mar; 149(3):907-911.e3. PubMed ID: 34952033 [TBL] [Abstract][Full Text] [Related]
8. Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies. Mizera D; Dziedzic R; Drynda A; Gradzikiewicz A; Jakieła B; Celińska-Löwenhoff M; Padjas A; Matyja-Bednarczyk A; Zaręba L; Bazan-Socha S Front Immunol; 2023; 14():1275892. PubMed ID: 37901210 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best. Salinas AF; Mortari EP; Terreri S; Quintarelli C; Pulvirenti F; Di Cecca S; Guercio M; Milito C; Bonanni L; Auria S; Romaggioli L; Cusano G; Albano C; Zaffina S; Perno CF; Spadaro G; Locatelli F; Carsetti R; Quinti I J Clin Immunol; 2021 Nov; 41(8):1709-1722. PubMed ID: 34669144 [TBL] [Abstract][Full Text] [Related]
10. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency. Quinti I; Locatelli F; Carsetti R Front Immunol; 2021; 12():815404. PubMed ID: 35126372 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine. Gupta S; Agrawal S; Sandoval A; Su H; Tran M; Demirdag Y J Clin Immunol; 2022 Jul; 42(5):914-922. PubMed ID: 35366743 [TBL] [Abstract][Full Text] [Related]
19. Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency. Rosenthal JA; Papa MP; Sanz M; Nicholes S; Holmberg CS; Bosque A; Keswani A; Amdur R; Lynch RM; Soriano-Sarabia N; Ein D Ann Allergy Asthma Immunol; 2023 Jun; 130(6):743-751.e3. PubMed ID: 36736722 [TBL] [Abstract][Full Text] [Related]
20. B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies. Pulvirenti F; Fernandez Salinas A; Milito C; Terreri S; Piano Mortari E; Quintarelli C; Di Cecca S; Lagnese G; Punziano A; Guercio M; Bonanni L; Auria S; Villani F; Albano C; Locatelli F; Spadaro G; Carsetti R; Quinti I Cells; 2021 Oct; 10(11):. PubMed ID: 34831138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]